Phenotypic analysis of plasma cells in bone marrow using flow cytometry in AL amyloidosis

References

• Buxbaum J. The amyloidoses. Rheumatology2nd ed., J H Klippel, P A Dieppe. Mosby, London 1998; 8.27.1–10
   Google Scholar
• Kyle R A, Gertz M A. Primary systemic amyloidosis. Clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45–59
   PubMed Web of Science ®Google Scholar
• Harada H, Kawano M M, Huang N, Harada Y, Iwato K, Tanabe O, Tanaka H, Sakai A, Asaoku H, Kuramoto A. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 1993; 81: 2658–2663
   PubMed Web of Science ®Google Scholar
• Huang N, Kawano M M, Harada H, Harada Y, Sakai A, Kuramoto A, Niwa O. Heterogeneous expression of a novel MPC‐1 antigen on myeloma cells. Possible involvement of MPC‐1 antigen in the adhesion of mature myeloma cells to bone marrow stromal cells. Blood 1993; 82: 3721–3729
   PubMed Web of Science ®Google Scholar
• Kawano M M, Huang N, Harada H, Harada Y, Sakai A, Tanaka H, Iwato K, Kuramoto A. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood 1993; 82: 564–570
   PubMed Web of Science ®Google Scholar
• Mahmoud M S, Ishikawa H, Fujii R, Kawano M M. Induction of CD45 expression and proliferation in U‐266 myeloma cell line by interleukin‐6. Blood 1998; 92: 3887–3897
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Mahmoud M S, Fujii R, Abroun S, Kawano M M. Proliferation of immature myeloma cells by interleukin‐6 is associated with CD45 expression in human multiple myeloma. Leuk Lymphoma 2000; 39: 51–55
   PubMed Web of Science ®Google Scholar
• Kawano M M, Mahmoud M S, Huang N, Lisukov I A, Mihara K, Tsujimoto T, Kuramoto A. High proportions of VLA‐5– immature myeloma cells correlated well with poor response to treatment in multiple myeloma. Br J Haematol 1995; 91: 860–864
   PubMed Web of Science ®Google Scholar
• Hoshii Y, Setoguchi M, Iwata T, Ueda J, Cui D, Kawano H, Condo T, Takahashi M, Ishihara T. Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol Int 2001; 51: 264–270
   PubMed Web of Science ®Google Scholar
• Kyle R A. Diagnostic criteria of multiple myeloma. Hematol Oncol Clin North Am 1992; 6: 347–358
   PubMed Web of Science ®Google Scholar
• Wu S S, Brady K, Anderson J J, Vezina R, Skinner M, Neiman R S, Wolf B C. The predictive value of bone marrow morphologic characteristics and immunostaining in primary (AL) amyloidosis. Am J Clin Pathol 1991; 96: 95–99
   PubMed Web of Science ®Google Scholar
• Gertz M A, Greipp P R, Kyle R A. Classification of amyloidosis by the detection of clonal excess of plasma cells in the bone marrow. J Lab Clin Med 1991; 118: 33–39
   PubMed Web of Science ®Google Scholar
• Perfetti V, Garini P, Vignarelli M C, Marinone M G, Zorzoli I, Merlini G. Diagnostic approach to and follow‐up of difficult cases of AL amyloidosis. Haematologica 1995; 80: 409–415
   PubMed Web of Science ®Google Scholar
• McElroy E A, Jr, Witzig T E, Gertz M A, Greipp P R, Kyle R A. Detection of monoclonal plasma cells in the peripheral blood of patients with primary amyloidosis. Br J Haematol 1998; 100: 326–327
   PubMed Web of Science ®Google Scholar
• Perfetti V, Ubbiali P, Magni M, Colli Vignarelli M, Casarini S, Matteucci P, Gianni A M, Merlini G. Cells with clonal light chains are present in peripheral blood at diagnosis and in apheretic stem cell harvests of primary amyloidosis. Bone Marrow Transplant 1999; 23: 323–327
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Kawano M M. Biological significance of heterogeneity in human myeloma cells. Int J Hematol 1998; 68: 363–370
   PubMed Web of Science ®Google Scholar
• Greipp P R, Raymond N M, Kyle R A, O'Fallon W M. Multiple myeloma. Significance of plasmablastic subtype in morphological classification. Blood 1985; 65: 305–310
   PubMed Web of Science ®Google Scholar
• Fujii R, Ishikawa H, Mahmoud M S, Asaoku H, Kawano M M. MPC‐1‐CD49e‐ immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL‐6 in human myelomas. Br J Haematol 1999; 105: 131–140
   PubMed Web of Science ®Google Scholar